Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016)

Achieve Life Sciences (ACHV) recorded quarterly Non-Current Deferred Tax Liability of $124000.0 in Q4 2016.

Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016) Analysis & Trends

Achieve Life Sciences has disclosed Non-Current Deferred Tax Liability across 1 years of filings, most recently posting $124000.0 for Q4 2016.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $124000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $124000.0 (changed N/A YoY) and the FY2016 annual result came in at $124000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability held at $124000.0 in Q4 2016.
Over five years, Non-Current Deferred Tax Liability peaked at $124000.0 in Q4 2016 and troughed at $124000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	Achieve Life Sciences	93.71 Mn	63.22 Mn	-

Download Data

Date	Value
Dec 31, 2016	124,000.00
Dec 31, 2016	124,000.00